Latest period
$169.53M
YoY change
+24.9%
5Y CAGR
-26.4%
Peak year (2020)
$968.97M
Latest annual
$209.86M
Cash on Hand history chart for Kodiak Sciences (KOD) from 2016 to 2025
Latest: $209.86M
Cash on Hand growth chart for Kodiak Sciences (KOD) from 2016 to 2025
Latest: +24.9%
Cash on Hand history table for Kodiak Sciences (KOD) from 2016 to 2025
| 2025 | $209.86M | +24.9% | +$41.79M | ||
| 2024 | $168.07M | -41.1% | −$117.43M | ||
| 2023 | $285.51M | -40.4% | −$193.43M | ||
| 2022 | $478.93M | -34.5% | −$252.58M | ||
| 2021 | $731.51M | -24.5% | −$237.46M | ||
| 2020 | $968.97M | +188.0% | +$632.49M | ||
| 2019 | $336.48M | +281.3% | +$248.23M | ||
| 2018 | $88.25M | +6226.5% | +$86.86M | ||
| 2017 | $1.40M | -85.5% | −$8.23M | ||
| 2016 | $9.62M | — | — |
- 2025$209.86M+24.9%
- 2024$168.07M-41.1%
- 2023$285.51M-40.4%
- 2022$478.93M-34.5%
- 2021$731.51M-24.5%
- 2020$968.97M+188.0%
- 2019$336.48M+281.3%
- 2018$88.25M+6226.5%
- 2017$1.40M-85.5%
- 2016$9.62M—
Cash on Hand values are taken from Kodiak Sciences's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Cash on Hand at Kodiak Sciences (KOD)
According to Kodiak Sciences's latest reported financial statements, the company's latest reported cash and short-term investments is $169.53M. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for net leverage and total assets for the share of assets held in cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2025's annual cash and short-term investments for Kodiak Sciences (KOD) came in at $209.86M – grew 24.9% year-over-year.
Across 2020–2025 (5 years), Kodiak Sciences cash and short-term investments produced a CAGR of -26.4% – with a net decline across the window.
Kodiak Sciences cash and short-term investments plunged from $968.97M in 2020 to $209.86M in 2025, a 78.3% drawdown.
The record annual cash and short-term investments stands at $968.97M, reached in 2020; the historical low of $1.40M was recorded in 2017.
Kodiak Sciences Cash on Hand by Year
Kodiak Sciences Cash on Hand 2025: $209.86M
Kodiak Sciences cash and short-term investments in 2025 was $209.86M, grew 24.9% from 2024.
Kodiak Sciences Cash on Hand 2024: $168.07M
2024's cash and short-term investments for Kodiak Sciences came in at $168.07M, plunged 41.1% below 2023.
Kodiak Sciences Cash on Hand 2023: $285.51M
Kodiak Sciences posted cash and short-term investments of $285.51M in 2023, plunged 40.4% below 2022.
Kodiak Sciences Cash on Hand 2022: $478.93M
In 2022, Kodiak Sciences reported cash and short-term investments of $478.93M, plunged 34.5% below 2021.
Kodiak Sciences Cash on Hand 2021: $731.51M
Kodiak Sciences cash and short-term investments in 2021 was $731.51M.
See more financial history for Kodiak Sciences (KOD).
Sector peers by Cash on Hand
Healthcare peers of Kodiak Sciences (KOD), ranked by their latest cash and short-term investments
| $28.12B | |
| $20.10B | |
| $14.56B | |
| $9.13B | |
| $7.27B | |
| $5.74B | |
| $5.26B | |
| $4.24B |
- $28.12B
- $20.10B
- $14.56B
- $9.13B
- $7.27B
- $5.74B
- $5.26B
- $4.24B
Frequently asked questions
Kodiak Sciences (KOD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation